Form 424B7 Harmony Biosciences Hold

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Form 424B7 Harmony Biosciences Hold

Goldman Sachs Reiterates Sell Rating on Harmony Biosciences Holdings Inc. (HRMY)

October 30, 2024 6:10 AM EDT

Goldman Sachs analyst Corinne Jenkins reiterated a Sell rating and $28.00 price target on Harmony Biosciences Holdings Inc. (NASDAQ: HRMY)

The analyst comments "HRMY is finished the trading day higher (16% vs 0% XBI) after reporting 3Q24 product revenues of $186.0M, 1%/1% vs. FactSet consensus and GS estimates of $184.1M/$184.0M. The company reported average patients on therapy at ~6,800 vs. 6,550 during 2Q24, a 250... More